Alkeon Capital Management
MYOK

Alkeon Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Alkeon Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,000
Closed -$2.9M – 164
2020
Q2 		$2.9M Hold
30,000
– – 0.01% 138
2020
Q1 		$1.41M Buy
30,000
+15,000
+100% +$961K 0.01% 132
2019
Q4 		$1.09M Buy
+15,000
New +$910K ﹤0.01% 131

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Alkeon Capital Management's MYOK Position: Q3 2020 in Review

Alkeon Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 30,000 shares — an estimated $2.9M sold.

Alkeon Capital Management first reported a position in MYOK in Q4 2019 and held it in 3 quarters. The position peaked at $2.9M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Alkeon Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Alkeon Capital Management sold 30,000 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $2.9M.
  • Alkeon Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • Alkeon Capital Management's MyoKardia, Inc. Common Stock position peaked at $2.9M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Alkeon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.